Connect With Us:
REPORT ID 488

Global Nanopartiele Drug Delivery System (NDDS) Market Research Report 2017

Publish Date
04-Dec-17
Pages
118
Format
Electronic (PDF)

Full report description 
In this report, the global Nanopartiele Drug Delivery System (NDDS) market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report is segmented into several key Regions, with production, consumption, revenue (million USD), market share and growth rate of Nanopartiele Drug Delivery System (NDDS) in these regions, from 2012 to 2022 (forecast), covering
    North America
    Europe
    China
    Japan
    Southeast Asia
    India
Global Nanopartiele Drug Delivery System (NDDS) market competition by top manufacturers, with production, price, revenue (value) and market share for each manufacturer; the top players including
    Pfizer, Inc.
    AbbVie, Inc.
    Merck & Co., Inc.
    Johnson & Johnson
    Roche
    Bayer
    Novartis International AG
    Celgene Corporation
    Capsulution Pharma
    Perrigo Company plc
    Amgen Inc.
    Teva Pharmaceutical Industries Ltd
On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
    Nanocrystals
    Nanoparticles
    Liposomes
    Micelles
    Nanotubes
    Others
On the basis of the end users/applications, this report focuses on the status and outlook for major applications/end users, consumption (sales), market share and growth rate for each application, including
    Neurology
    Oncology
    Cardiovascular/Physiology
    Anti-inflammatory/Immunology
    Anti-infective
    Others

If you have any special requirements, please let us know and we will offer you the report as you want.
Table of contents 
Table of Contents

Global Nanopartiele Drug Delivery System (NDDS) Market Research Report 2017
1 Nanopartiele Drug Delivery System (NDDS) Market Overview
    1.1 Product Overview and Scope of Nanopartiele Drug Delivery System (NDDS)
    1.2 Nanopartiele Drug Delivery System (NDDS) Segment by Type (Product Category)
        1.2.1 Global Nanopartiele Drug Delivery System (NDDS) Production and CAGR (%) Comparison by Type (Product Category)(2012-2022)
        1.2.2 Global Nanopartiele Drug Delivery System (NDDS) Production Market Share by Type (Product Category) in 2016
        1.2.3 Nanocrystals
        1.2.4 Nanoparticles
        1.2.5 Liposomes
        1.2.6 Micelles
        1.2.7 Nanotubes
        1.2.8 Others
    1.3 Global Nanopartiele Drug Delivery System (NDDS) Segment by Application
        1.3.1 Nanopartiele Drug Delivery System (NDDS) Consumption (Sales) Comparison by Application (2012-2022)
        1.3.2 Neurology
        1.3.3 Oncology
        1.3.4 Cardiovascular/Physiology
        1.3.5 Anti-inflammatory/Immunology
        1.3.6 Anti-infective
        1.3.7 Others
    1.4 Global Nanopartiele Drug Delivery System (NDDS) Market by Region (2012-2022)
        1.4.1 Global Nanopartiele Drug Delivery System (NDDS) Market Size (Value) and CAGR (%) Comparison by Region (2012-2022)
        1.4.2 North America Status and Prospect (2012-2022)
        1.4.3 Europe Status and Prospect (2012-2022)
        1.4.4 China Status and Prospect (2012-2022)
        1.4.5 Japan Status and Prospect (2012-2022)
        1.4.6 Southeast Asia Status and Prospect (2012-2022)
        1.4.7 India Status and Prospect (2012-2022)
    1.5 Global Market Size (Value) of Nanopartiele Drug Delivery System (NDDS) (2012-2022)
        1.5.1 Global Nanopartiele Drug Delivery System (NDDS) Revenue Status and Outlook (2012-2022)
        1.5.2 Global Nanopartiele Drug Delivery System (NDDS) Capacity, Production Status and Outlook (2012-2022)

2 Global Nanopartiele Drug Delivery System (NDDS) Market Competition by Manufacturers
    2.1 Global Nanopartiele Drug Delivery System (NDDS) Capacity, Production and Share by Manufacturers (2012-2017)
        2.1.1 Global Nanopartiele Drug Delivery System (NDDS) Capacity and Share by Manufacturers (2012-2017)
        2.1.2 Global Nanopartiele Drug Delivery System (NDDS) Production and Share by Manufacturers (2012-2017)
    2.2 Global Nanopartiele Drug Delivery System (NDDS) Revenue and Share by Manufacturers (2012-2017)
    2.3 Global Nanopartiele Drug Delivery System (NDDS) Average Price by Manufacturers (2012-2017)
    2.4 Manufacturers Nanopartiele Drug Delivery System (NDDS) Manufacturing Base Distribution, Sales Area and Product Type
    2.5 Nanopartiele Drug Delivery System (NDDS) Market Competitive Situation and Trends
        2.5.1 Nanopartiele Drug Delivery System (NDDS) Market Concentration Rate
        2.5.2 Nanopartiele Drug Delivery System (NDDS) Market Share of Top 3 and Top 5 Manufacturers
        2.5.3 Mergers & Acquisitions, Expansion

3 Global Nanopartiele Drug Delivery System (NDDS) Capacity, Production, Revenue (Value) by Region (2012-2017)
    3.1 Global Nanopartiele Drug Delivery System (NDDS) Capacity and Market Share by Region (2012-2017)
    3.2 Global Nanopartiele Drug Delivery System (NDDS) Production and Market Share by Region (2012-2017)
    3.3 Global Nanopartiele Drug Delivery System (NDDS) Revenue (Value) and Market Share by Region (2012-2017)
    3.4 Global Nanopartiele Drug Delivery System (NDDS) Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
    3.5 North America Nanopartiele Drug Delivery System (NDDS) Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
    3.6 Europe Nanopartiele Drug Delivery System (NDDS) Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
    3.7 China Nanopartiele Drug Delivery System (NDDS) Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
    3.8 Japan Nanopartiele Drug Delivery System (NDDS) Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
    3.9 Southeast Asia Nanopartiele Drug Delivery System (NDDS) Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
    3.10 India Nanopartiele Drug Delivery System (NDDS) Capacity, Production, Revenue, Price and Gross Margin (2012-2017)

4 Global Nanopartiele Drug Delivery System (NDDS) Supply (Production), Consumption, Export, Import by Region (2012-2017)
    4.1 Global Nanopartiele Drug Delivery System (NDDS) Consumption by Region (2012-2017)
    4.2 North America Nanopartiele Drug Delivery System (NDDS) Production, Consumption, Export, Import (2012-2017)
    4.3 Europe Nanopartiele Drug Delivery System (NDDS) Production, Consumption, Export, Import (2012-2017)
    4.4 China Nanopartiele Drug Delivery System (NDDS) Production, Consumption, Export, Import (2012-2017)
    4.5 Japan Nanopartiele Drug Delivery System (NDDS) Production, Consumption, Export, Import (2012-2017)
    4.6 Southeast Asia Nanopartiele Drug Delivery System (NDDS) Production, Consumption, Export, Import (2012-2017)
    4.7 India Nanopartiele Drug Delivery System (NDDS) Production, Consumption, Export, Import (2012-2017)

5 Global Nanopartiele Drug Delivery System (NDDS) Production, Revenue (Value), Price Trend by Type
    5.1 Global Nanopartiele Drug Delivery System (NDDS) Production and Market Share by Type (2012-2017)
    5.2 Global Nanopartiele Drug Delivery System (NDDS) Revenue and Market Share by Type (2012-2017)
    5.3 Global Nanopartiele Drug Delivery System (NDDS) Price by Type (2012-2017)
    5.4 Global Nanopartiele Drug Delivery System (NDDS) Production Growth by Type (2012-2017)

6 Global Nanopartiele Drug Delivery System (NDDS) Market Analysis by Application
    6.1 Global Nanopartiele Drug Delivery System (NDDS) Consumption and Market Share by Application (2012-2017)
    6.2 Global Nanopartiele Drug Delivery System (NDDS) Consumption Growth Rate by Application (2012-2017)
    6.3 Market Drivers and Opportunities
        6.3.1 Potential Applications
        6.3.2 Emerging Markets/Countries

7 Global Nanopartiele Drug Delivery System (NDDS) Manufacturers Profiles/Analysis
    7.1 Pfizer, Inc.
        7.1.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        7.1.2 Nanopartiele Drug Delivery System (NDDS) Product Category, Application and Specification
            7.1.2.1 Product A
            7.1.2.2 Product B
        7.1.3 Pfizer, Inc. Nanopartiele Drug Delivery System (NDDS) Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
        7.1.4 Main Business/Business Overview
    7.2 AbbVie, Inc.
        7.2.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        7.2.2 Nanopartiele Drug Delivery System (NDDS) Product Category, Application and Specification
            7.2.2.1 Product A
            7.2.2.2 Product B
        7.2.3 AbbVie, Inc. Nanopartiele Drug Delivery System (NDDS) Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
        7.2.4 Main Business/Business Overview
    7.3 Merck & Co., Inc.
        7.3.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        7.3.2 Nanopartiele Drug Delivery System (NDDS) Product Category, Application and Specification
            7.3.2.1 Product A
            7.3.2.2 Product B
        7.3.3 Merck & Co., Inc. Nanopartiele Drug Delivery System (NDDS) Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
        7.3.4 Main Business/Business Overview
    7.4 Johnson & Johnson
        7.4.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        7.4.2 Nanopartiele Drug Delivery System (NDDS) Product Category, Application and Specification
            7.4.2.1 Product A
            7.4.2.2 Product B
        7.4.3 Johnson & Johnson Nanopartiele Drug Delivery System (NDDS) Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
        7.4.4 Main Business/Business Overview
    7.5 Roche
        7.5.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        7.5.2 Nanopartiele Drug Delivery System (NDDS) Product Category, Application and Specification
            7.5.2.1 Product A
            7.5.2.2 Product B
        7.5.3 Roche Nanopartiele Drug Delivery System (NDDS) Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
        7.5.4 Main Business/Business Overview
    7.6 Bayer
        7.6.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        7.6.2 Nanopartiele Drug Delivery System (NDDS) Product Category, Application and Specification
            7.6.2.1 Product A
            7.6.2.2 Product B
        7.6.3 Bayer Nanopartiele Drug Delivery System (NDDS) Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
        7.6.4 Main Business/Business Overview
    7.7 Novartis International AG
        7.7.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        7.7.2 Nanopartiele Drug Delivery System (NDDS) Product Category, Application and Specification
            7.7.2.1 Product A
            7.7.2.2 Product B
        7.7.3 Novartis International AG Nanopartiele Drug Delivery System (NDDS) Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
        7.7.4 Main Business/Business Overview
    7.8 Celgene Corporation
        7.8.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        7.8.2 Nanopartiele Drug Delivery System (NDDS) Product Category, Application and Specification
            7.8.2.1 Product A
            7.8.2.2 Product B
        7.8.3 Celgene Corporation Nanopartiele Drug Delivery System (NDDS) Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
        7.8.4 Main Business/Business Overview
    7.9 Capsulution Pharma
        7.9.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        7.9.2 Nanopartiele Drug Delivery System (NDDS) Product Category, Application and Specification
            7.9.2.1 Product A
            7.9.2.2 Product B
        7.9.3 Capsulution Pharma Nanopartiele Drug Delivery System (NDDS) Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
        7.9.4 Main Business/Business Overview
    7.10 Perrigo Company plc
        7.10.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        7.10.2 Nanopartiele Drug Delivery System (NDDS) Product Category, Application and Specification
            7.10.2.1 Product A
            7.10.2.2 Product B
        7.10.3 Perrigo Company plc Nanopartiele Drug Delivery System (NDDS) Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
        7.10.4 Main Business/Business Overview
    7.11 Amgen Inc.
    7.12 Teva Pharmaceutical Industries Ltd

8 Nanopartiele Drug Delivery System (NDDS) Manufacturing Cost Analysis
    8.1 Nanopartiele Drug Delivery System (NDDS) Key Raw Materials Analysis
       8.1.1 Key Raw Materials
       8.1.2 Price Trend of Key Raw Materials
       8.1.3 Key Suppliers of Raw Materials
       8.1.4 Market Concentration Rate of Raw Materials
    8.2 Proportion of Manufacturing Cost Structure
       8.2.1 Raw Materials
       8.2.2 Labor Cost
       8.2.3 Manufacturing Expenses
    8.3 Manufacturing Process Analysis of Nanopartiele Drug Delivery System (NDDS)

9 Industrial Chain, Sourcing Strategy and Downstream Buyers
    9.1 Nanopartiele Drug Delivery System (NDDS) Industrial Chain Analysis
    9.2 Upstream Raw Materials Sourcing
    9.3 Raw Materials Sources of Nanopartiele Drug Delivery System (NDDS) Major Manufacturers in 2015
    9.4 Downstream Buyers

10 Marketing Strategy Analysis, Distributors/Traders
    10.1 Marketing Channel
        10.1.1 Direct Marketing
        10.1.2 Indirect Marketing
        10.1.3 Marketing Channel Development Trend
    10.2 Market Positioning
        10.2.1 Pricing Strategy
        10.2.2 Brand Strategy
        10.2.3 Target Client
    10.3 Distributors/Traders List

11 Market Effect Factors Analysis
    11.1 Technology Progress/Risk
        11.1.1 Substitutes Threat
        11.1.2 Technology Progress in Related Industry
    11.2 Consumer Needs/Customer Preference Change
    11.3 Economic/Political Environmental Change

12 Global Nanopartiele Drug Delivery System (NDDS) Market Forecast (2017-2022)
    12.1 Global Nanopartiele Drug Delivery System (NDDS) Capacity, Production, Revenue Forecast (2017-2022)
        12.1.1 Global Nanopartiele Drug Delivery System (NDDS) Capacity, Production and Growth Rate Forecast (2017-2022)
        12.1.2 Global Nanopartiele Drug Delivery System (NDDS) Revenue and Growth Rate Forecast (2017-2022)
        12.1.3 Global Nanopartiele Drug Delivery System (NDDS) Price and Trend Forecast (2017-2022)
    12.2 Global Nanopartiele Drug Delivery System (NDDS) Production, Consumption , Import and Export Forecast by Region (2017-2022)
        12.2.1 North America Nanopartiele Drug Delivery System (NDDS) Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
        12.2.2 Europe Nanopartiele Drug Delivery System (NDDS) Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
        12.2.3 China Nanopartiele Drug Delivery System (NDDS) Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
        12.2.4 Japan Nanopartiele Drug Delivery System (NDDS) Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
        12.2.5 Southeast Asia Nanopartiele Drug Delivery System (NDDS) Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
        12.2.6 India Nanopartiele Drug Delivery System (NDDS) Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
    12.3 Global Nanopartiele Drug Delivery System (NDDS) Production, Revenue and Price Forecast by Type (2017-2022)
    12.4 Global Nanopartiele Drug Delivery System (NDDS) Consumption Forecast by Application (2017-2022)

13 Research Findings and Conclusion

14 Appendix
    14.1 Methodology/Research Approach
        14.1.1 Research Programs/Design
        14.1.2 Market Size Estimation
        14.1.3 Market Breakdown and Data Triangulation
    14.2 Data Source
        14.2.1 Secondary Sources
        14.2.2 Primary Sources
    14.3 Disclaimer